Article ID Journal Published Year Pages File Type
10965847 Vaccine 2013 6 Pages PDF
Abstract
By using a simple analytic approach to compute vaccine coverage in aging cohorts from claims data, we show that PCV13 coverage rose rapidly as the PCV7 program was replaced. These estimates, validated against a CDC sentinel surveillance system in 8 states, should enable early documentation of the PCV13 impact on pneumococcal disease in the US. Moreover, they demonstrate the feasibility of tracking uptake patterns in near real-time even with simple summary counts of medical claims data.
Related Topics
Life Sciences Immunology and Microbiology Immunology
Authors
, , , , ,